Mark R. Lanning's most recent trade in Atricure Inc was a trade of 10,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 5, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atricure Inc | Mark R. Lanning | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Atricure Inc | Mark R. Lanning | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.17 per share. | 05 May 2021 | 10,000 | 140,886 (0%) | 0% | 14.2 | 141,700 | Common Stock |